Company: SVREW
Filing Date: 2025-01-31
Form Type: 424B5
Source: 0001213900-25-008656
Chunk: 52

Company: SaverOne 2014 Ltd.
Filing Date: 2025-01-31
Form: 424B5
Chunk 52
---
 |
| Share capital and premium                                                  |     |                     |  118,559 |   |     |                           |  32,043 |   |
| Capital reserves in respect of share-based payment                         |     |                     |   10,523 |   |     |                           |   2,844 |   |
| Accumulated deficit                                                        |     |                     | (119,528 | ) |     |                           | (32,305 | ) |
| Total shareholders’ capital                                                
 equity                                                                     |     |                     |    9,554 |   |     |                           |   2,582 |   |

| (1) | Calculated                                                                               
 using the exchange rate reported by the Bank of Israel for June 30, 2023, at the rate of 
 one U.S. dollar per NIS 3.70.                                                            |

Unless otherwise indicated,
the number of ordinary shares outstanding prior to and after this offering is based on 28,321,656 ordinary shares outstanding as of June
30, 2023. The number of ordinary shares referred to above to be outstanding after this offering and, unless otherwise indicated, the
other information in this prospectus, excludes as of such date:

| ● | 1,850,230                                                                                 
 ordinary shares issuable upon exercise of options outstanding ‌under the Saverone 2014    
 Ltd. 2015 Share Incentive Plan, or the 2015 Plan, at a weighted average exercise price of 
 NIS ‌5.63 (approximately $1.52) per share;                                                |

| ● | 1,149,770                                                         
 ordinary shares reserved for future issuance under our 2015 Plan; |

| ● | 787,550                                                                                          
 ordinary shares issuable upon the exercise of warrants granted to the underwriters in connection 
 with our initial public offering in the United States in June 2022, or IPO;                      |

| ● | 16,383,410                                                                               
 ordinary shares issuable upon the exercise of warrants sold in our IPO in June 2022; and |

| ● | 24,459,240 ordinary shares issued and additional ordinary shares that we may issue from time to time to YA II PN, LTD., or YA, pursuant to that certain Standby Equity Purchase Agreement dated June 5, 2023 that we entered into with YA (the “Purchase Agreement”), as amended on December 11, 2023 and March 25, 2024 (the “